Tuesday, 17 November 2026European Markets

AB SCIENCE Stock Was 12.42% Up On Monday

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(vianews) - the market ended the session with ab science (ab.pa) rising 12.42% to €2.67 on monday, following the last session's upward trend. cac 40 slid 0.94% to €7,068.16, after two sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

ab science's last close was €2.38, 75% under its 52-week high of €9.50.

about ab science

ab science s.a., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. its lead compound is the masitinib, a tyrosine kinase inhibitor that is in phase iii clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, alzheimer's, severe asthma, and mastocytosis diseases, as well as in phase ii clinical trial to treat covid-19. the company is also developing ab8939, a synthetic microtubule destabiliser for haematology indications. the company markets its masitinib under the masivet brand in europe. ab science s.a. was incorporated in 2001 and is headquartered in paris, france.

earnings per share

as for profitability, ab science has a trailing twelve months eps of €-0.3.

revenue growth

year-on-year quarterly revenue growth declined by 58.3%, now sitting on 958k for the twelve trailing months.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ab science's stock is considered to be oversold (<=20).

moving average

ab science's worth is way below its 50-day moving average of €3.77 and way under its 200-day moving average of €5.72.

more news about ab science (ab.pa).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 2 Oct 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›